PMID: 2498927Jan 1, 1989Paper

Discovery of antidepressant activity by forced swimming test may depend on pre-exposure of rats to a stressful situation

Psychopharmacology
F BorsiniA Meli

Abstract

Antidepressant-induced anti-immobility effects have been assessed in animals exposed or not to a pretest session using the forced swimming test. Desipramine, maprotiline, mianserine (15 and 30 mg/kg), nomifensine (2.5 and 5 mg/kg), d-amphetamine (1 and 2 mg/kg) and muscimol (1 and 2 mg/kg), unlike imipramine (15 and 30 mg/kg), LY-171555 (0.1 and 0.2 mg/kg) and scopolamine (0.5 and 0.1 mg/kg), did not reduce immobility time in rats which had not received the pretest session. On the other hand, all of the drugs tested reduced immobility time in rats exposed to a pretest session. In addition, the degree of antiimmobility effects of desipramine (20 mg/kg) and nomifensine (5 mg/kg) increased proportionally with the level of water (0, 4, 15 and 30 cm) to which animals were exposed at the time of pretest. Furthermore, desipramine reduced immobility time in rats pre-exposed to types of stress different from forced swimming, cold, restraint or foot-shock. All drugs were injected intraperitoneally three times, 24, 5 and 1 h before testing. The present findings suggest that a stressful pretest session may reveal pharmacological properties of antidepressants in the forced swimming test. This is also substantiated by the fact that diazepam ...Continue Reading

References

Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Aug 3, 1978·Nature·J HawkinsJ D Moore
Sep 16, 1976·Nature·A M ThierryJ Glowinski
Dec 1, 1975·Journal of Neurochemistry·P Krogsgaard-LarsenR M McCulloch
Feb 18, 1986·European Journal of Pharmacology·F BorsiniA Meli
Sep 1, 1986·Biological Psychiatry·S C DilsaverN E Alessi
Jan 1, 1986·Physiology & Behavior·F BorsiniA Meli
Sep 1, 1985·Brain Research Bulletin·F Borsini
Jun 29, 1981·Brain Research·J H SkerrittG A Johnston
Apr 15, 1982·Brain Research·E A Stone, J E Platt
Jan 1, 1984·Psychopharmacology·P Willner
Jul 26, 1984·The New England Journal of Medicine·S H Snyder
Aug 27, 1982·European Journal of Pharmacology·J E Platt, E A Stone
Jun 19, 1981·European Journal of Pharmacology·Y KitadaS Satoh
Jan 1, 1981·Neuroscience and Biobehavioral Reviews·R J KatzB J Carroll

❮ Previous
Next ❯

Citations

Feb 1, 1994·Breast Cancer Research and Treatment·L Hilakivi-ClarkeM E Lippman
Nov 1, 1991·Journal of Chemical Ecology·E L Abel, M G Subramanian
Feb 19, 2011·Psychopharmacology·Li WangStephanie C Dulawa
Jun 13, 1994·European Journal of Pharmacology·E L Abel, J H Hannigan
Aug 1, 1990·Physiology & Behavior·E L Abel, P J Bilitzke
Apr 1, 1992·Physiology & Behavior·H H Van DijkenF J Tilders
Jan 1, 1994·Physiology & Behavior·C A Bruner, I Vargas
Oct 1, 1990·Pharmacology, Biochemistry, and Behavior·L A Hilakivi-ClarkeM Linnoila
Sep 1, 1991·Pharmacology, Biochemistry, and Behavior·G R Cuadra, V A Molina
May 1, 1993·Pharmacology, Biochemistry, and Behavior·K D Dwyer, E J Roy
Jun 1, 1995·Pharmacology, Biochemistry, and Behavior·C H Beck, H C Fibiger
May 1, 1992·Brain Research Bulletin·G D SchillerD H Overstreet
Jul 5, 2003·Biological Psychiatry·John F CryanAthina Markou
Sep 22, 2001·Pharmacology, Biochemistry, and Behavior·G HédouJ Feldon
Jan 4, 1998·Pharmacology, Biochemistry, and Behavior·T LopesK M Boje
Feb 26, 1998·Pharmacology, Biochemistry, and Behavior·B H AliM O Tanira
Jan 1, 1996·Pharmacology & Therapeutics·D J Balfour, K O Fagerström
Aug 23, 2002·Behavioural Brain Research·Erika Estrada-CamarenaCarolina López-Rubalcava
Nov 26, 1999·Archives of Medical Research·L Martínez-MotaM Saavedra
Jul 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·María Llorens-MartínJosé L Trejo
May 1, 1991·British Journal of Addiction·D J Balfour
Jan 25, 2011·Genes, Brain, and Behavior·W ItoA Morozov
Oct 15, 2010·Bioscience, Biotechnology, and Biochemistry·Aya KageyamaHidehiko Yokogoshi
Jan 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Xin-Yun LuWei Zhang
May 7, 2013·Expert Opinion on Investigational Drugs·Lokesh PathakAshish Dhir

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.